/Celigo Application News

Improve Seahorse XF results using direct cell counting

Improve Seahorse XF results using direct cell counting. An important step in performing SeahorseTM XF cell metabolism analysis is normalization of the resultant data.

By |2019-08-29T13:09:21+00:00August 29th, 2019|Categories: Celigo Application News, Latest News|Tags: , , |0 Comments

Video Workflow-at-a-Glance: NK Cell-Mediated Cytotoxicity Assay

Directly image and count calcein AM-labeled target cells in a 96-well plate using Celigo image cytometer. Concurrent imaging and analysis in 8 minutes.

Video Workflow-at-a-Glance: Seahorse™ Normalization Assay

Celigo Image Cytometer provides a fast, effective, and cell stress-free technique to count cells plated onto uncoated or coated culture plates.

Normalizing Seahorse™ XF Data with Label-Free Cell Counting

How to use Celigo image cytometry to normalize Seahorse™ XF data and eliminate time-consuming protein-based process.

By |2018-11-20T22:36:09+00:00November 20th, 2018|Categories: Celigo Application News, Latest News|Tags: , , , |0 Comments

Evaluating Anticancer Drug Compounds using Image Cytometry

Image-based, automated analysis of 3-D tumor spheroids in microwell plates is becoming standard practice for the evaluation of anticancer drug compounds.

By |2018-10-12T17:57:35+00:00September 17th, 2018|Categories: Celigo Application News, Latest News|0 Comments

Automated Cell Counters: Accurate, Reproducible Cell Counts for the Entire Cell Therapy Workflow

Cellometer automated cell counters have been facilitating CAR T manufacturing with accurate cell counting and analysis since 2010.

Celigo Provides Image-Based Proof of Single-Cell Clonality

The FDA identifies clonality as one of the most crucial steps in guaranteeing cell line quality and safety. The Celigo Image Cytometer makes single cell sorting easy.

Poster: High-throughput immune complex analysis method for CAR T cell-mediated cytotoxicity using the Celigo Image Cytometer

Download our Poster Abstract: Cancer immunotherapy has been gaining momentum in the field of cancer research. Specifically, Chimeric Antigen Receptor (CAR) T cell technology have introduced new methods to combat cancer. Direct cell-mediated cytotoxicity assays are required to assess the killing capability of the engineered CAR T cells. Traditionally, these assays are conducted by measuring the amount of released Chromium, calcein AM, or LDH molecules after the target cancer cells are killed with CAR T cells. These methods require a large amount of target cells which may not be ideal when working with donor primary samples. Additionally, they cannot [...]

By |2018-06-21T14:01:23+00:00April 5th, 2018|Categories: Celigo Application News, Latest News|Tags: , , , |0 Comments

High throughput, high-resolution image acquisition for DNA damage detection

Celigo playing an important role in high throughput, high-resolution image acquisition for DNA damage detection. The Celigo S captures 16 images of each well that are then stitched into a single representation Open access article: Next generation high throughput DNA damage detection platform for genotoxic compound screening

By |2018-06-15T15:35:51+00:00March 2nd, 2018|Categories: Celigo Application News, Latest News|Tags: , , , |0 Comments

Benefits of direct high-throughput cell counting in immuno-oncology research

By directly imaging and counting every cell in a well over a course of a drug treatment, the Celigo can perform the cytotoxicity assays in a label-free format.